Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	32.90	-26.45	-39.43
Graham Fair Price	23.66	7.27	5.88
PEG	0.00	0.00	0.00
Price/Book	-20.58	1.80	2.27
Price/Cash Flow	47.10	-12.81	-24.22
Prices/Earnings	53.13	-9.37	-20.00
Price/Sales	-56.32	72.75	166.55
Price/FCF	47.10	-12.81	-24.22
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	19.47	-2.47	-3.07
Operating Margin	17.02	-2.52	-3.04
ROA	-64.73	-0.04	-0.03
ROE	-0.03	-0.05	-69.45
ROIC	-0.03	-0.05	-51.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	124.07	89.41	-27.94
Days Sales Outstanding (DSO)	236.56	290.75	22.91
Inventory Turnover	0.73	1.01	38.77
Debt/Capitalization	0.04	0.05	17.57
Quick Ratio	7.01	5.34	-23.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	7.35	6.98	-5.00
Cash	5.45	4.50	-17.48
Capex	-0.42	-0.55	-29.94
Free Cash Flow	-0.69	-0.98	-42.62
Revenue	0.10	0.17	72.74
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	7.91	6.09	-22.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.89	12.15	-28.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating